# Outcome of Neo-adjuvant Chemotherapy Followed by Breast Conservative Surgery in Breast Cancer in Upper Egypt

> **NCT03696004** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 45 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** FEC-100

## Key facts

- **NCT ID:** NCT03696004
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12
- **Primary completion:** 2019-06
- **Final completion:** 2020-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2018-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03696004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03696004, "Outcome of Neo-adjuvant Chemotherapy Followed by Breast Conservative Surgery in Breast Cancer in Upper Egypt". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT03696004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*